Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

SELL
$13.31 - $34.88 $10,648 - $27,904
-800 Closed
0 $0
Q1 2022

Apr 21, 2022

SELL
$20.26 - $32.36 $46,598 - $74,428
-2,300 Reduced 74.19%
800 $23,000
Q3 2021

Oct 22, 2021

BUY
$29.75 - $37.99 $92,225 - $117,769
3,100 New
3,100 $97,000
Q4 2020

Jan 25, 2021

SELL
$35.51 - $54.03 $284,080 - $432,240
-8,000 Closed
0 $0
Q3 2020

Dec 14, 2020

BUY
$32.81 - $45.1 $262,480 - $360,800
8,000 New
8,000 $340,000

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $780M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.